Venom and Toxin as Targeted Therapy

• Egile nagusia: Kwok, Hang Fai (Henry) (auth)
• Formatua: Baliabide elektronikoa Liburu kapitulua
• Hizkuntza: ingelesa
• Argitaratua: MDPI - Multidisciplinary Digital Publishing Institute 2019
• Gaiak: Biology, life sciences; cane toad; n/a; B cell non-Hodgkin lymphoma; Malaysian cobras; complement system; decay accelerating factor; neuroblastoma; atopic dermatitis; complement dependent cytotoxicity; antioxidant enzymes; bacterial adhesion; cancer therapy; N. kaouthia; anuran skin secretion; frog; Apis mellifera syriaca; solid phase extraction; bee venom phospholipase A2 (bvPLA2); disintegrin; toad toxins; immunotoxins; ribosome-inactivating proteins; antimicrobial peptide (AMP); drug design; Moxetumomab pasudotox; snake venom; antiviral activity; in vitro effects; bombesin-related peptide; oxidative stress biomarkers; half-life; blood vessel formation; target therapy; 2; MYCN; indolealkylamines; Huachansu; membrane attack complex; bouganin; bee venom; SEM; anticancer activity; antimicrobial peptide; house dust mite extract (DFE); mannose receptor; O. hannah; bicarinalin; gastric cells; melittin; LC-ESI-MS; dermaseptin; smooth muscle; apoptosis; anticancer; N. sumatrana; Helicobacter pylori; inflammation; immunotherapy; atopic dermatitis (AD); immunotoxin; mantle cell lymphoma; clearance; mass spectrometry; Bougainvillea; rRNA N-glycosylase activity; fungal toxin; skin inflammation; targeted therapy; 4-dinitrochlorobenzene (DNCB); Bee venom; VEGF; Chansu; bufadienolides; obsessive-compulsive disorder (OCD); BLF1; antimicrobial activity; orellanine; VB6-845; acute lymphoblastic leukemia; ribosome-inactivating protein; CD206; molecular cloning; cancer; CD22; eIF4A
• Sarrera elektronikoa: DOAB: download the publication; DOAB: description of the publication

Targeted therapy has developed significantly in the last one and half decades, prescribing specific medications for treatment of particular diseases, such as cancer, diabetes, and heart disease. One of the most exciting recent developments in targeted therapies was the isolation of disease-specific...